5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine Dihydrochloride Dihydrate

被引：0
|
作者：
Kozanecka-Okupnik, Weronika [1 ]
Wurst, Klaus [2 ]
Neuner, Sandro [2 ]
Nerdinger, Sven [3 ]
Gelbrich, Thomas [4 ]
机构：
[1] Selvita Serv Sp zoo, Selvita Grp, Bobrzynskiego 14, PL-30348 Krakow, Poland
[2] Univ Innsbruck, Inst Gen Theoret & Inorgan Chem, Innrain 80-82, A-6020 Innsbruck, Austria
[3] Sandoz GmbH, Biochemiestr 10, A-6250 Kundl, Austria
[4] Univ Innsbruck, Inst Pharm, Innrain 52c, A-6020 Innsbruck, Austria
来源：
MOLBANK | 2023年 / 2023卷 / 02期
关键词：
crystal structure; hydrate; hydrogen bonding; kinase inhibitor; pharmaceuticals;
D O I：
10.3390/M1673
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
The dihydrochloride salt of pexidartinib was synthesized and the crystal structure of its dihydrate was determined from single crystal data. The asymmetric unit consists of one formula unit. In the pexidartinib molecule, the N atom of the central pyridine ring and the pyridine-N atom of the pyrrolopyridine group are both protonated. The pexidartinib molecule forms N-H & BULL;& BULL;& BULL;O and N-H & BULL;& BULL;& BULL;Cl interactions with neighboring water molecules and chloride ions, respectively. Water/chloride (O-H & BULL;& BULL;& BULL;Cl) and water/water (O-H & BULL;& BULL;& BULL;O) interactions are also observed. Collectively, these intermolecular interactions result in a complex H-bonded framework structure.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] (E)-3-[5-(Diphenylamino)thiophen-2-yl]1-(pyridin-3-yl)prop-2-en-1-one
    Li, Rui
    Li, Dan-Dan
    Wu, Jie-Ying
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1405 - +
  • [32] Synthesis of N-(3-arylmethyl-2-oxo-2,3-dihydroimidazo[1,2-a]pyridin-3-yl)benzamides
    Tu, Shujiang
    Zhang, Junyong
    Jia, Runhong
    Jiang, Bo
    Zhang, Yan
    Yao, Changsheng
    Jiang, Hong
    CHEMISTRY LETTERS, 2007, 36 (02) : 222 - 223
  • [33] Diaquabis[5-(pyrazin-2-yl-κN1)-3-(pyridin-3-yl)-1,2,4-triazolido-κN1]cadmium
    Yang, Jing-Jing
    Zhao, Jun
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : M1690 - U1364
  • [34] Crystal structure of N-(methyl(oxo)(1-(6-(trifluoromethyl)pyridin-3-yl)ethyl)-λ6-sulfanylidene)cyanamide, C10H10F3N3OS
    Ning, Xu
    Shi, Yun-Lian
    Shi, Xu-Gen
    Yang, Wen-Li
    Peng, Da-Yong
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (04): : 861 - 862
  • [35] The six-membered-ring azomethine N-((E)-{5-[(E)-(pyridin-3-ylimino)methyl]thiophen-2-yl}methylidene)pyridin-3-amine
    Bolduc, Andreanne
    Dufresne, Stephane
    Skene, W. G.
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2013, 69 : 1196 - +
  • [36] [3-(2-hydroxyphenyl)-5-phenyl-4,5-dihydropyrazol-1-yl](pyridin-3-yl)methanone
    Nie, Aihua
    Ghosh, Sutapa
    Huang, Ziwei
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O3776 - O3777
  • [37] Synthesis of 2-methoxy-2-methyl-3-{6-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]pyridin-3-yl}propanoic acid, a dual PPARα/γ agonist
    Humphries, Paul S.
    Do, Quyen-Quyen T.
    Wilhite, David M.
    TETRAHEDRON LETTERS, 2009, 50 (16) : 1765 - 1767
  • [38] Crystal structure of 1-(2-(pyridin-2-yl)-5-(pyridin-3-yl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one, C14H12N4O2
    Yu, Xiang
    Huang, Ling
    Zhou, Xing-Ji
    Chen, Ya-Fang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1065 - 1066
  • [39] 6-Hydroxy-4-(pyridin-3-yl)-5-(2-thienyl-carbonyl)-6-trifluoromethyl-3,4,5,6-tetrahydropyrimidin-2(1H)-one
    Li, Gong-Chun
    Ju, Zhi-Yu
    Wang, Hong-Sheng
    Niu, Yu-Jiao
    Yang, Feng-Ling
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O2852 - U507
  • [40] Diaquabis[5-(pyrazin-2-yl-kN(1))-3-(pyridin-3-yl)-1,2,4-triazolido-kappa N-1]-zinc
    Wang, Ye-Nan
    Dong, Wen-Wen
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : M116 - +
12345